Tofacitinib Use in Elderly With Ulcerative Colitis: Comparative Analysis of Safety and Efficacy

被引：0
|
作者：
Almomani, Ashraf [1 ]
Khan, Osama Sherjeel [1 ]
Channagiri, Ritu N. A. [1 ]
Abu-Hammour, Mohamad-Noor [2 ]
Abdel-Razeq, Rashid [2 ]
Ansari, Zaid N. A. [1 ]
Hitawala, Asif [1 ]
Ahmad, Akram [1 ]
Kumar, Prabhat NA. [2 ]
Chadalavada, Pravallika N. A. [1 ]
Castro, Fernando N. A. [1 ]
Rahman, Asad Ur [1 ]
机构：
[1] Cleveland Clin Florida, Weston, FL USA
[2] Cleveland Clin, Cleveland, OH USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001035136.35392.fa
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1442
引用
收藏
页码：S1036 / S1037
页数：2
相关论文
共 50 条
  • [1] Ulcerative colitis: efficacy and safety of tofacitinib studied
    Kessing, Richard
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (10):
  • [2] Tofacitinib in Ulcerative Colitis-evolving Efficacy and Safety
    Tiwari, Avinash
    Ashraf, Aadil
    Bharali, Pankaj
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2023, 57 (04) : 429 - 429
  • [3] Efficacy and Safety of Extended Induction With Tofacitinib for the Treatment of Ulcerative Colitis
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    Quirk, Daniel
    Wang, Wenjin
    Nduaka, Chudy, I
    Mukherjee, Arnab
    Su, Chinyu
    Sands, Bruce E.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (08) : 1821 - +
  • [4] Pharmacology and safety of tofacitinib in ulcerative colitis
    Lopez-Sanroman, Antonio
    Esplugues, Juan, V
    Domenech, Eugeni
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (01): : 39 - 48
  • [5] Efficacy of tofacitinib treatment in ulcerative colitis
    Panes, Julian
    Gisbert, Javier P.
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (06): : 403 - 412
  • [6] ANALYSIS OF THE IMPACT OF BODY MASS INDEX ON EFFICACY AND SAFETY IN THE TOFACITINIB OCTAVE ULCERATIVE COLITIS PROGRAM
    Farraye, Francis A.
    Qazi, Taha
    Kotze, Paulo G.
    Moore, Gregory T.
    Kayhan, Cem
    Mundayat, Rajiv
    Maller, Eric S.
    Su, Chinyu
    Soonasra, Arif
    GASTROENTEROLOGY, 2019, 156 (06) : S1111 - S1112
  • [7] Analysis of the impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis programme
    Farraye, F. A.
    Qazi, T.
    Kotze, P. G.
    Moore, G. T.
    Kayhan, C.
    Mundayat, R.
    Maller, E.
    Su, C.
    Soonasra, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S301 - S302
  • [8] Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
    McNally, M.
    Keating, E.
    Gray, E.
    McCormick, E.
    Carroll, A.
    Palmer, C.
    Kennedy, U.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    Egan, L.
    Slattery, E.
    Ryan, B.
    McNamara, D.
    O'Connor, A.
    Breslin, N.
    O'Donnell, S.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I431 - I431
  • [9] Efficacy and safety of tofacitinib in Ulcerative Colitis patients with extraintestinal manifestations in OCTAVE Open
    Rubin, D. T.
    Vavricka, S. R.
    Armuzzi, A.
    Dubinsky, M. C.
    Sharara, A. I.
    Modesto, I.
    Fellmann, M.
    Liguori, G.
    Lawendy, N.
    Cadatal, M. J.
    Lichtenstein, G. R.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I538 - I539
  • [10] Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
    McNally, M.
    Keating, E.
    Gray, E.
    McCormick, E.
    Carroll, A.
    Palmer, C.
    Kennedy, U.
    McKiernan, S.
    MacCarthy, F.
    Dunne, C.
    Hartery, K.
    Egan, L.
    Slattery, E.
    Ryan, B.
    McNamara, D.
    O'Connor, A.
    Breslin, N.
    O'Donnell, S.
    Cullen, G.
    Mulcahy, H.
    Sheridan, J.
    Doherty, G.
    Kevans, D.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I431 - I431
12345